MEN.L

Molecular Energies
Molecular Energies - Agreement signed between G-Mobility and CPH2
28th November 2023, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8237U
Molecular Energies PLC
28 November 2023
 

28 November 2023

 

MOLECULAR ENERGIES PLC

("MEN" or the "Company")

 

Agreement signed between G-Mobility and Clean Power Hydrogen

 

Molecular Energies (AIM: MEN), the international energy company, provides an update relating to G-Mobility and CPH2.

 

G-Mobility, a subsidiary of Green House Capital, the green division of Molecular which is progressing a spin out and IPO notes the RNS announcement of Clean Power Hydrogen PLC ("CPH2") made today in relation to a non-binding framework agreement having been signed between G-Mobility and CPH2.

 

Under the non-binding framework agreement the parties will explore a licensing arrangement for the manufacture and sale of CPH2's electrolysers in the Mercosur trading bloc of countries in South America.

 

G-Mobility believes there is a significant market opportunity for the supply of domestically produced electrolysers in the large Mercosur trading bloc including Brazil, Paraguay, Uruguay and Argentina, and this agreement is enhances the ability of G-Mobility to be a key player in this market.

 

For more information, please visit www.molecularenergiesplc.com or contact:

 

 

Molecular Energies PLC

Peter Levine, Chairman

Rob Shepherd, Group FD

 

+44 (0)20 7016 7950

info@molecularenergiesplc.com

Cavendish Capital Markets Limited (Nominated Advisor and Broker)

Simon Hicks, George Dollemore

 

+44 (0)20 7220 0500

Tavistock (Financial PR & IR)

Simon Hudson, Nick Elwes, Charles Baister

+44 (0)20 7920 3150

 

 

Notes to Editors

Molecular Energies PLC is an AIM listed company at the forefront of energy development and has interests across the energy spectrum, from an oil and gas project to the green and alternative energy sector.

 

The Company currently has an oil exploration asset in Paraguay. The Company has two separate subdivisions which are focused on early-stage opportunities in the green and/or alternative energy sub-sector.

 

Activities in the green and alternative energy space are being carried out direct through Molecular and under the Green House Capital brand and through AIM listed Atome Energy PLC, a green hydrogen, ammonia, and fertiliser company operating in Paraguay, Costa Rica and Iceland, in which Molecular currently has 20.5%.

 

With a strong strategic and institutional base of support, no third-party financial debt and a Chairman whose interests as the largest shareholder are aligned to those of its shareholders, Molecular gives UK investors access to an energy growth story combined with world class standards of corporate governance, environmental and social responsibility.

 

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDNKOBNFBDDDDB]]>
TwitterFacebookLinkedIn